These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 37118632)

  • 21. Serum neurofilament light chain in genetic frontotemporal dementia: a longitudinal, multicentre cohort study.
    van der Ende EL; Meeter LH; Poos JM; Panman JL; Jiskoot LC; Dopper EGP; Papma JM; de Jong FJ; Verberk IMW; Teunissen C; Rizopoulos D; Heller C; Convery RS; Moore KM; Bocchetta M; Neason M; Cash DM; Borroni B; Galimberti D; Sanchez-Valle R; Laforce R; Moreno F; Synofzik M; Graff C; Masellis M; Carmela Tartaglia M; Rowe JB; Vandenberghe R; Finger E; Tagliavini F; de Mendonça A; Santana I; Butler C; Ducharme S; Gerhard A; Danek A; Levin J; Otto M; Frisoni GB; Cappa S; Pijnenburg YAL; Rohrer JD; van Swieten JC;
    Lancet Neurol; 2019 Dec; 18(12):1103-1111. PubMed ID: 31701893
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum neurofilament light chain in progressive supranuclear palsy.
    Donker Kaat L; Meeter LH; Chiu WZ; Melhem S; Boon AJW; Blennow K; Zetterberg H; van Swieten JC
    Parkinsonism Relat Disord; 2018 Nov; 56():98-101. PubMed ID: 29937097
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma Neurofilament Light Chain as a Translational Biomarker of Aging and Neurodegeneration in Dogs.
    Panek WK; Gruen ME; Murdoch DM; Marek RD; Stachel AF; Mowat FM; Saker KE; Olby NJ
    Mol Neurobiol; 2020 Jul; 57(7):3143-3149. PubMed ID: 32472519
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma neurofilament light chain levels in patients with MS switching from injectable therapies to fingolimod.
    Piehl F; Kockum I; Khademi M; Blennow K; Lycke J; Zetterberg H; Olsson T
    Mult Scler; 2018 Jul; 24(8):1046-1054. PubMed ID: 28627962
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma neurofilament light chain: A potential prognostic biomarker of dementia in adult Down syndrome patients.
    Shinomoto M; Kasai T; Tatebe H; Kondo M; Ohmichi T; Morimoto M; Chiyonobu T; Terada N; Allsop D; Yokota I; Mizuno T; Tokuda T
    PLoS One; 2019; 14(4):e0211575. PubMed ID: 30951523
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neurofilament light chain as a biomarker in neurological disorders.
    Gaetani L; Blennow K; Calabresi P; Di Filippo M; Parnetti L; Zetterberg H
    J Neurol Neurosurg Psychiatry; 2019 Aug; 90(8):870-881. PubMed ID: 30967444
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combination of Serum Neurofilament Light Chain Levels and MRI Markers to Predict Cognitive Function in Ischemic Stroke.
    Peng Y; Li Q; Qin L; He Y; Luo X; Lan Y; Chen X; Wang X; Wang QM
    Neurorehabil Neural Repair; 2021 Mar; 35(3):247-255. PubMed ID: 33522401
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma tau, neurofilament light chain and amyloid-β levels and risk of dementia; a population-based cohort study.
    de Wolf F; Ghanbari M; Licher S; McRae-McKee K; Gras L; Weverling GJ; Wermeling P; Sedaghat S; Ikram MK; Waziry R; Koudstaal W; Klap J; Kostense S; Hofman A; Anderson R; Goudsmit J; Ikram MA
    Brain; 2020 Apr; 143(4):1220-1232. PubMed ID: 32206776
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of Plasma Neurofilament Light With Small Vessel Disease Burden in Nondemented Elderly: A Longitudinal Study.
    Qu Y; Tan CC; Shen XN; Li HQ; Cui M; Tan L; Dong Q; Yu JT;
    Stroke; 2021 Mar; 52(3):896-904. PubMed ID: 33517704
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum neurofilament light chain levels as a marker of upper motor neuron degeneration in patients with Amyotrophic Lateral Sclerosis.
    Gille B; De Schaepdryver M; Goossens J; Dedeene L; De Vocht J; Oldoni E; Goris A; Van Den Bosch L; Depreitere B; Claeys KG; Tournoy J; Van Damme P; Poesen K
    Neuropathol Appl Neurobiol; 2019 Apr; 45(3):291-304. PubMed ID: 29908069
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma concentration of neurofilament light chain protein decreases after switching from tenofovir disoproxil fumarate to tenofovir alafenamide fumarate.
    Hermansson L; Yilmaz A; Price RW; Nilsson S; McCallister S; Makadzange T; Das M; Zetterberg H; Blennow K; Gisslen M
    PLoS One; 2019; 14(12):e0226276. PubMed ID: 31826005
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of Plasma Neurofilament Light With Neurodegeneration in Patients With Alzheimer Disease.
    Mattsson N; Andreasson U; Zetterberg H; Blennow K;
    JAMA Neurol; 2017 May; 74(5):557-566. PubMed ID: 28346578
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum and cerebrospinal fluid neurofilament light chain in patients with central nervous system infections caused by varicella-zoster virus.
    Tyrberg T; Nilsson S; Blennow K; Zetterberg H; Grahn A
    J Neurovirol; 2020 Oct; 26(5):719-726. PubMed ID: 32816287
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neurofilament light chain protein as a marker of neuronal injury: review of its use in HIV-1 infection and reference values for HIV-negative controls.
    Yilmaz A; Blennow K; Hagberg L; Nilsson S; Price RW; Schouten J; Spudich S; Underwood J; Zetterberg H; Gisslén M
    Expert Rev Mol Diagn; 2017 Aug; 17(8):761-770. PubMed ID: 28598205
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased neurofilament light chain blood levels in neurodegenerative neurological diseases.
    Gaiottino J; Norgren N; Dobson R; Topping J; Nissim A; Malaspina A; Bestwick JP; Monsch AU; Regeniter A; Lindberg RL; Kappos L; Leppert D; Petzold A; Giovannoni G; Kuhle J
    PLoS One; 2013; 8(9):e75091. PubMed ID: 24073237
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dimethyl fumarate decreases neurofilament light chain in CSF and blood of treatment naïve relapsing MS patients.
    Sejbaek T; Nielsen HH; Penner N; Plavina T; Mendoza JP; Martin NA; Elkjaer ML; Ravnborg MH; Illes Z
    J Neurol Neurosurg Psychiatry; 2019 Dec; 90(12):1324-1330. PubMed ID: 31611264
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma NfL, clinical subtypes and motor progression in Parkinson's disease.
    Pilotto A; Imarisio A; Conforti F; Scalvini A; Masciocchi S; Nocivelli S; Turrone R; Gipponi S; Cottini E; Borroni B; Rizzetti MC; Pizzi M; Bonanni L; Sturchio A; Espay AJ; Zetterberg H; Ashton NJ; Hye A; Padovani A
    Parkinsonism Relat Disord; 2021 Jun; 87():41-47. PubMed ID: 33964785
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum neurofilament light chain levels reflect cortical neurodegeneration in de novo Parkinson's disease.
    Sampedro F; Pérez-González R; Martínez-Horta S; Marín-Lahoz J; Pagonabarraga J; Kulisevsky J
    Parkinsonism Relat Disord; 2020 May; 74():43-49. PubMed ID: 32334380
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma neurofilament light chain levels predict improvement in late phase after stroke.
    Stokowska A; Bunketorp Käll L; Blomstrand C; Simrén J; Nilsson M; Zetterberg H; Blennow K; Pekny M; Pekna M
    Eur J Neurol; 2021 Jul; 28(7):2218-2228. PubMed ID: 33811783
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma neurofilament light chain levels in Alzheimer's disease.
    Zhou W; Zhang J; Ye F; Xu G; Su H; Su Y; Zhang X;
    Neurosci Lett; 2017 May; 650():60-64. PubMed ID: 28428015
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.